MAPK8 and breast cancer: Additionally, two individual MAPK8 siRNAs with confirmed knockdown efficiency (Supplementary Fig. 1e) reversed the stiffness-induced phenotype (Fig. 5c, top row) and suppressed cell growth proliferation (Fig. 5c, bottom row) in HCC1143 human breast cancer cells.